Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2020

Open Access 01-12-2020 | Muscular Dystrophy | Case report

Muscular involvement and tendon contracture in limb-girdle muscular dystrophy 2Y: a mild adult phenotype and literature review

Authors: Xuelin Feng, Jinlang Wu, Wenbiao Xian, Bing Liao, Songjie Liao, Xiaoli Yao, Weixi Zhang

Published in: BMC Musculoskeletal Disorders | Issue 1/2020

Login to get access

Abstract

Background

Limb girdle muscular dystrophy type 2Y (LGMD2Y) is a rare subgroup of limb girdle muscular dystrophy featuring limb-girdle weakness, tendon contracture and cardiac involvement. It is caused by the mutation of TOR1AIP1, which encodes nuclear membrane protein LAP1 (lamina-associated polypeptide 1) and comprises heterogeneous phenotypes. The present study reported a patient with a novel homozygous TOR1AIP1 mutation that presented with selective muscle weakness, which further expanded the phenotype of LGMD2Y- and TOR1AIP1-associated nuclear envelopathies.

Case presentation

A 40-year-old male presented with Achilles tendon contracture and muscle weakness that bothered him from 8 years old. While the strength of his distal and proximal upper limbs was severely impaired, the function of his lower limbs was relatively spared. Muscle pathology showed dystrophic features, and electron microscopy showed ultrastructural abnormalities of disrupted muscle nuclei envelopes. Whole-exome sequencing showed a frameshift mutation in TOR1AIP1 (c.98dupC).

Conclusion

We reported a novel mild phenotype of LGMD2Y with relatively selective distal upper limb weakness and joint contracture and revealed the heterogeneity of LGDM2Y and the role of the LAP1 isoform by literature review.
Literature
1.
go back to reference Guglieri M, Straub V, Bushby K, Lochmüller H. Limb–girdle muscular dystrophies. Curr Opin Neurol. 2008;21(5):576–84.CrossRef Guglieri M, Straub V, Bushby K, Lochmüller H. Limb–girdle muscular dystrophies. Curr Opin Neurol. 2008;21(5):576–84.CrossRef
4.
go back to reference Bhatia A, Mobley BC, Cogan J, Koziura ME, Brokamp E, Phillips J, et al. Magnetic resonance imaging characteristics in case of TOR1AIP1 muscular dystrophy. Clin Imaging. 2019;58:108–13.CrossRef Bhatia A, Mobley BC, Cogan J, Koziura ME, Brokamp E, Phillips J, et al. Magnetic resonance imaging characteristics in case of TOR1AIP1 muscular dystrophy. Clin Imaging. 2019;58:108–13.CrossRef
6.
go back to reference Kondo Y, Kondoh J, Hayashi D, Ban T, Takagi M, Kamei Y, et al. Molecular cloning of one isotype of human lamina-associated polypeptide 1s and a topological analysis using its deletion mutants. Biochem Biophys Res Commun. 2002;294(4):770–8.CrossRef Kondo Y, Kondoh J, Hayashi D, Ban T, Takagi M, Kamei Y, et al. Molecular cloning of one isotype of human lamina-associated polypeptide 1s and a topological analysis using its deletion mutants. Biochem Biophys Res Commun. 2002;294(4):770–8.CrossRef
8.
go back to reference Walton JN. Gardner-Medwin D. Progressive muscular dystrophy and the myotonic disorders. In: JN W, editor. Disorders of voluntary muscles. 1981. p. p481–524. Walton JN. Gardner-Medwin D. Progressive muscular dystrophy and the myotonic disorders. In: JN W, editor. Disorders of voluntary muscles. 1981. p. p481–524.
9.
go back to reference ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul;166(1):111–7. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul;166(1):111–7.
10.
go back to reference Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ. Clinical trial in Duchenne dystrophy. I. the design of the protocol. Muscle Nerve. 1981;4(3):186–97.CrossRef Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ. Clinical trial in Duchenne dystrophy. I. the design of the protocol. Muscle Nerve. 1981;4(3):186–97.CrossRef
11.
go back to reference Mayhew A, Mazzone ES, Eagle M, Duong T, Ash M, Decostre V, et al. Development of the performance of the upper limb module for Duchenne muscular dystrophy. Dev Med Child Neurol. 2013;55(11):1038–45.CrossRef Mayhew A, Mazzone ES, Eagle M, Duong T, Ash M, Decostre V, et al. Development of the performance of the upper limb module for Duchenne muscular dystrophy. Dev Med Child Neurol. 2013;55(11):1038–45.CrossRef
12.
go back to reference Li H. Durbin R. Fast and accurate short read alignment with Burrows–Wheeler transform bioinformatics. 2009;25(14):1754–60.PubMed Li H. Durbin R. Fast and accurate short read alignment with Burrows–Wheeler transform bioinformatics. 2009;25(14):1754–60.PubMed
13.
go back to reference McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297–303.CrossRef McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297–303.CrossRef
14.
go back to reference Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.CrossRef Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.CrossRef
15.
go back to reference Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405.CrossRef Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405.CrossRef
16.
go back to reference Dorboz I, Coutelier M, Bertrand AT, Caberg JH, Elmaleh-Bergès M, Lainé J, et al. Severe dystonia, cerebellar atrophy, and cardiomyopathy likely caused by a missense mutation in TOR1AIP1. Orphanet J Rare Dis. 2014;9:174.CrossRef Dorboz I, Coutelier M, Bertrand AT, Caberg JH, Elmaleh-Bergès M, Lainé J, et al. Severe dystonia, cerebellar atrophy, and cardiomyopathy likely caused by a missense mutation in TOR1AIP1. Orphanet J Rare Dis. 2014;9:174.CrossRef
18.
go back to reference Santos M, Domingues SC, Costa P, Muller T, Galozzi S, Marcus K, et al. Identification of a novel human LAP1 isoform that is regulated by protein phosphorylation. PLoS One. 2014;9(12):e113732.CrossRef Santos M, Domingues SC, Costa P, Muller T, Galozzi S, Marcus K, et al. Identification of a novel human LAP1 isoform that is regulated by protein phosphorylation. PLoS One. 2014;9(12):e113732.CrossRef
19.
go back to reference Nagano A, Koga R, Ogawa M, Kurano Y, Kawada J, Okada R, et al. Emerin deficiency at the nuclear membrane in patients with Emery-Dreif uss muscular dystrophy. Nat Genet. 1996;12(3):254–9.CrossRef Nagano A, Koga R, Ogawa M, Kurano Y, Kawada J, Okada R, et al. Emerin deficiency at the nuclear membrane in patients with Emery-Dreif uss muscular dystrophy. Nat Genet. 1996;12(3):254–9.CrossRef
20.
go back to reference Zhang Q, Bethmann C, Worth NF, Davies JD, Wasner C, Feuer A, et al. Nesprin-1 and-2 are involved in the pathogenesis of Emery–Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum Mol Genet. 2007;16(23):2816–33.CrossRef Zhang Q, Bethmann C, Worth NF, Davies JD, Wasner C, Feuer A, et al. Nesprin-1 and-2 are involved in the pathogenesis of Emery–Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum Mol Genet. 2007;16(23):2816–33.CrossRef
21.
go back to reference Worman HJ, Dauer WT. The nuclear envelope: an intriguing focal point for Neurogenetic disease. Neurotherapeutics. 2014;11(4):764–72.CrossRef Worman HJ, Dauer WT. The nuclear envelope: an intriguing focal point for Neurogenetic disease. Neurotherapeutics. 2014;11(4):764–72.CrossRef
22.
go back to reference Noreau A, Bourassa CV, Szuto A, Levert A, Dobrzeniecka S, Gauthier J, et al. SYNE1 mutations in autosomal recessive cerebellar ataxia. JAMA Neurol. 2013;70(10):1296–301.PubMed Noreau A, Bourassa CV, Szuto A, Levert A, Dobrzeniecka S, Gauthier J, et al. SYNE1 mutations in autosomal recessive cerebellar ataxia. JAMA Neurol. 2013;70(10):1296–301.PubMed
23.
go back to reference Peng Y, Ye W, Chen Z, Peng H, Wang P, Hou X, et al. Identifying SYNE1 Ataxia with novel mutations in a Chinese population. Front Neurol. 2018;9(December):1–10. Peng Y, Ye W, Chen Z, Peng H, Wang P, Hou X, et al. Identifying SYNE1 Ataxia with novel mutations in a Chinese population. Front Neurol. 2018;9(December):1–10.
Metadata
Title
Muscular involvement and tendon contracture in limb-girdle muscular dystrophy 2Y: a mild adult phenotype and literature review
Authors
Xuelin Feng
Jinlang Wu
Wenbiao Xian
Bing Liao
Songjie Liao
Xiaoli Yao
Weixi Zhang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2020
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-020-03616-4

Other articles of this Issue 1/2020

BMC Musculoskeletal Disorders 1/2020 Go to the issue